Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...

Amid a reckoning for the gene therapy field, Vertex Pharmaceuticals has joined a growing list of companies paring back their ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish biotech ...

Hikers should consider visiting the Carpathian Alps, which includes Romania’s Transylvanian Alps, instead of the Swiss Alps. It’s not only a cost-effective option, but this mountain range has ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

After consecutive setbacks at the FDA, Regeneron's string of recent troubles with its Eylea franchise is continuing to pull ...

Swiss pharmaceutical firm Novartis on Tuesday reported better-than-expected first-quarter sales and raised its full-year ...

International Business Machines said Monday it plans to invest $150 billion in the U.S. over the next five years, the latest ...

For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...

Deborah Ball is the the Singapore-based Asia Editor for The Wall Street Journal. She was formerly based in London as the ...

Wall Street powered to its second-best weekly advance of 2025 on Friday, with the benchmark S&P 500 (SP500) jumping nearly 5%. For the week, the S&P advanced +4 ...